PTA Balloon Catheter & Drug-Coated Balloon Market Size, Share & Analysis | Global | 2020-2026 | MedCore | Segmented by: PTA Balloon Type (Standard, High-Pressure, Large, Small, Specialty) & Setting (Hospitals, Office-Based Labs) & DCBs by Segment (SFA, BTK, AV Access)

  • Year: 2020
  • Scope: 10 Years
  • Region: Global
  • Type: MedCore

The global PTA balloon catheter market size is estimated to increase over the forecast period to exceed $971.9 million in 2026. The global drug-coated balloon market size is expected to reach over $1,659.9 million in 2026.

The majority of the global PTA balloon catheter market share was controlled by C.R. Bard (BD) and Boston Scientific. This global market research includes 0.014”-0.035” balloons, high-pressure balloons, large balloons greater than 12mm in diameter and specialty balloons. Specialty balloons include cryoplasty balloons, cutting balloons, scoring balloons and other balloons that provide special functionalities that are not featured in traditional devices. The value of the total PTA balloon catheter market is expected to appreciate over the forecast period.

The global drug-coated balloon market share was controlled by C.R. Bard (BD) and Medtronic. The analysis includes DCBs used in the superficial femoral artery (SFA) and AV access procedures. The market was reduced considerably, following the FDA’s re-examination of paclitaxel use, covered in detail in the report.

Market Data Included

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Procedure Volumes
  • Market Drivers & Limiters
  • Market Forecasts Until 2026, and Historical Data to 2016
  • Recent Mergers & Acquisitions
  • Disease Overviews
  • Company Profiles, Product Portfolios, and SWOT for Top Competitors

PTA Balloon Catheter Market Insights

The largest market for PTA balloon catheters was the North American region. Within this region, hospitals comprised the strong majority of the total PTA balloon catheter market in 2019. Due to the large procedural shift moving towards outpatient facilities, owing to reimbursement differences, this ratio has declined significantly in the past few years. Globally, physicians are embracing the use of smaller balloons in procedures where standard balloons were historically used.

Drug-Coated Balloons Market Insights

The value of the DCB market has increased rapidly since launching in late 2014. The North American market for drug-coated balloons (DCBs) experienced a large shock in 2019, resulting from the FDA’s concerns over paclitaxel. Globally, markets saw strong negative shocks. However, the DCB market is expected to rebound, with strong growth expected over the forecast period.

Market Share Insights

The global PTA Balloon Catheter and Drug-Coated Balloon market was controlled by C.R Bard (BD).

PTA & DCB Balloon Market Leader

C.R Bard (BD) was the market share leader in the global PTA Balloon Catheter and Drug-Coated Balloon market. C. R. Bard’s Lutonix® 035 DCB – Dysfunctional AV Fistula Indication was the only DCB with approval for use in AV access procedures in the United States. More details on product development and the competitive landscape including new product launches and main challenges are described in details on this report.

Research Regional Coverage

Throughout this report, iData Research has covered over 70 countries across the globe in great detail. Each global region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:

  • North America (the United States and Canada)
  • Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
  • Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
  • Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
  • Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
  • Africa South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)



FREE Sample Report

Boston Scientific
Abbott Vascular
C. R. Bard (BD)
Cook Medical
Cardinal Health
  For more details contact an iData Research Product Advisor.

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology